Abstract Background Bleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these
Transcatheter heart valves technologies
Abstract Background Bleeding and stroke are frequent complications after transcatheter aortic valve implantation (TAVI). The mortality risk associated with these
Transcatheter heart valves technologies
Abstract Background Acute intraoperative hypercapnia and respiratory acidosis, which can occur during monitored anaesthesia care (MAC), pose significant cardiopulmonary risks
Transcatheter heart valves technologies
Abstract Background Paravalvular leakage (PVL) and conduction disorders that require permanent pacemaker implantation (PPI) remain clinically relevant challenges after transcatheter
Transcatheter heart valves technologies
Abstract Background Older adults with severe aortic stenosis (AS) may receive care in a nursing home (NH) prior to undergoing
Transcatheter heart valves technologies
Abstract Background In 2019, the US Food and Drug Administration (FDA) approved transcatheter aortic valve replacement (TAVR) for low‐risk patients
Transcatheter heart valves technologies
Abstract Aims We aimed to evaluate transcatheter mitral valve implantation (TMVI) using predominantly balloon‐expandable transcatheter heart valves (THV) in patients
Transcatheter heart valves technologies
Abstract Background Elevated aortic valve gradients are common after transcatheter aortic valve implantation for degenerated surgical aortic valve replacement bioprostheses,
Transcatheter heart valves technologies
Abstract Background Mitral regurgitation (MR) is frequent in patients with aortic stenosis (AS). Although primary MR is an established negative
Transcatheter heart valves technologies
Abstract More than mild paravalvular leak (PVL) following transcatheter aortic valve implantation (TAVI) is associated with a twofold increase in